Gaudium IVF
GAUDIUMIVF
Open Date
20 Feb '26
Close Dates
24 Feb '26
Price Range
₹75 - ₹79
Min Investment
₹14,931
Lot Size
189
Listing at
NSE/BSE
Issue Size
₹1,46,20,340
IPO Document
About Gaudium IVF IPO
Incorporated in March 2015, Gaudium IVF and Women Health Limited have engaged in In Vitro Fertilization (IVF) treatments throughout India and have expanded into several states utilizing a hub-and-spoke model.
The company operates over thirty locations, which include seven hubs (centres) and twenty-eight spokes. The organization has entered into a strategic alliance with Infertility Experts, known as Spokes, to achieve the mutual objective of raising awareness regarding Assisted Reproductive Technology (ART) and In Vitro Fertilization (IVF) treatments.
The company serves patients from various countries, including Canada, the United Kingdom, the United States, Kenya, South Africa, and Oman.
The company has centres in major cities: two in Delhi (Janakpuri, Kailash Colony), and one each in Mumbai (Khar West), Ludhiana, Srinagar, Patna, and Bangalore, covering key locations across India.
The company offers specialized fertility services, including In Vitro Fertilization (IVF), Intracytoplasmic Sperm Injection (ICSI), Intrauterine Insemination (IUI), and ovulation induction. Our treatments are designed for various infertility challenges for both genders. We also provide comprehensive gynaecological care for PCOD/PCOS and endometriosis, as well as high-risk pregnancy management for women with complex fertility histories or health conditions.
Gaudium IVF IPO Subscription Breakdown
| Investory Category | Subscription Percentage | Amount Raised (₹ Crores) |
|---|---|---|
| Qualified Institutional Buyers (QIBs) | 50% | 7310170 crores |
| Non-Institutional Investors (NIIs | 15% | 2193051 crores |
| Retail Individual Investors (RIIs) | 35% | 5117119 crores |
Optivalue Tek Consulting Ltd Financial Highlights
Gaudium IVF’s total income 0 by 0% and total expenses 0 by 0%, resulting in an EBITDA 0 by 0% and a profit after tax (PAT) 0 by 0% between March 31,2025 and March 31, 2026.
100
90
80
70
60
50
40
30
20
10
0
Gaudium IVF IPO Strengths & Weaknesses
Patient-Centric Approach
Expert team
Using next-gen INTEGRA Ti labs for ICSI.
Highly Technical USG Guided Services
Established central hubs in prime urban locations
including Mumbai
Bangalore
Delhi NCR
and Patna.
Asset Light Business Model
Gaudium IVF IPO Important Dates & Issue Details
| Allotment Date | Listing Date |
|---|---|
| 25 Feb '26 | 27 Feb '26 |
Gaudium IVF IPO Lot Size and Investment Details
| Minimum Lot Size | 189 shares |
| Maximum Lot Size (Retail) | 6237 shares |
The lot size of Gaudium IVF ipo has been designed to ensure broad participation while maintaining optimal price discovery.
How to Apply for Gaudium IVF IPO
- Log in to your Choice account
- Select IPO
- Enter the number of lots and your price
- Verify UPI ID
- Complete the transaction on your UPI app
